샘플 요청 목록

 카트 문의
시장보고서
상품코드
1775027

세계의 비위관 시장

Nasogastric Tubes
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 466 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

비위관 세계 시장은 2030년까지 7억 10만 달러에 달할 전망

2024년에 5억 4,340만 달러로 추정되는 비위관 세계 시장은 분석 기간 2024-2030년에 CAGR 4.3%로 성장하여 2030년에는 7억 10만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 성인 환자는 CAGR 4.9%를 기록하며 분석 기간 종료시에는 3억 9,990만 달러에 달할 것으로 예측됩니다. 소아 환자 부문의 성장률은 분석 기간 동안 CAGR 3.7%로 추정됩니다.

미국 시장은 1억 4,800만 달러로 추정, 중국은 CAGR 8.0%로 성장 예측

미국의 비위관 시장은 2024년에 1억 4,800만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 8.0%로 성장하여 2030년에는 1억 4,460만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.7%와 3.4%로 예측됩니다. 유럽에서는 독일이 CAGR 약 2.5%로 성장할 것으로 예측됩니다.

비위관 세계 시장 동향 - 주요 동향 및 촉진요인 정리

비위관 시장은 의료 및 영양 수요를 충족시키기 위해 어떻게 진화하고 있는가?

비위관(NG 튜브) 시장은 환자의 편안함과 치료 효율을 높이는 재료, 디자인, 적용 기술의 개선으로 큰 발전을 거듭하고 있습니다. NG 튜브는 경장영양, 약물투여, 위감압에 널리 사용되고 있으며, 병원, 재가 간호 환경, 중환자실(ICU)에서 중요한 도구로 사용되고 있습니다. 기존의 폴리염화비닐을 기본으로 한 튜브를 실리콘이나 폴리우레탄과 같은 보다 유연하고 생체적합성이 높은 소재로 점차 대체되고 있습니다. 또한, 막힘 방지 및 항균 코팅된 NG 튜브의 개발로 감염과 막힘을 최소화하여 환자의 예후를 개선하고 있습니다. 연하장애, 신경질환, 소화기 질환의 유병률 증가는 특히 고령화 사회와 중증 환자에서 비위관 수요를 더욱 증가시키고 있습니다. 재택의료 서비스의 확대는 장기 경장영양 솔루션의 필요성에 박차를 가하고 있으며, NG 튜브는 만성질환 관리에 필수적인 요소로 자리 잡고 있습니다.

다양한 헬스케어 분야에서 비위관 수요가 증가하는 이유는 무엇일까?

뇌졸중, 암, 신경질환 등 경장영양을 필요로 하는 질환의 발생률이 증가함에 따라 NG 튜브의 사용량이 크게 증가하고 있습니다. 병원이나 의료 시설에서는 중증 환자의 단기 영양 공급을 위해 장기 요양 시설이나 재가 의료 서비스 제공자는 지속적인 영양 공급을 위해 이 기구를 활용하고 있습니다. 연하장애로 이어지는 두경부암의 유병률 증가는 시장 확대에 더욱 기여하고 있습니다. 또한, NG 튜브는 응급 의료 및 외상 치료에서 중요한 역할을 하고 있으며, 위장의 감압 및 섭취한 독소를 흡입하는 데 사용됩니다. 미숙아나 선천성 기형을 가진 영아들은 특수한 영양 보충 방법을 필요로 하는 경우가 많기 때문에 소아 의료 및 신생아 의료 분야에서도 NG 튜브에 대한 수요가 증가하고 있습니다. 또한, 수술 후 영양관리가 필요한 수술이 증가함에 따라, 특히 소화기 수술과 비만 수술에서 NG 튜브 시장이 강화되고 있습니다.

기술 혁신과 규제 개발은 어떻게 시장을 형성하고 있는가?

비위관 업계에서는 안전성 향상, 합병증 감소, 환자 편의성 향상을 위한 몇 가지 기술 혁신이 이루어지고 있습니다. 방사선 불투과성 및 색상으로 구분된 비위관 도입으로 비위관 사용의 중요한 문제인 삽입 위치 확인이 개선되어 오삽입의 위험을 줄일 수 있게 되었습니다. pH 민감도 표시기와 전자기식 유치 확인 시스템의 개발로 튜브의 위치 결정 정확도가 더욱 향상되어 X-ray 확인에 대한 의존도를 낮추고 방사선 피폭을 최소화할 수 있게 되었습니다. 또한, 항균 코팅과 하이드로겔 베이스의 NG 튜브는 박테리아의 콜로니 형성을 줄이고 감염을 예방하는 능력으로 인기를 끌고 있습니다. FDA와 유럽의약품청(EMA)과 같은 규제 기관은 NG 튜브의 안전성과 유효성을 보장하기 위해 보다 엄격한 가이드라인을 시행하고 있으며, 제조업체는 고품질의 표준화된 제품에 대한 투자를 장려하고 있습니다. 의료 시설에서 감염 관리와 환자 안전을 우선시하는 경향이 강화되고 있으며, 고급 NG 솔루션에 대한 수요는 확대될 것으로 예상됩니다.

비위관 시장을 이끄는 주요 성장 요인은 무엇인가?

비위관 시장의 성장은 삼킴 장애 및 위장 장애의 유병률 증가, 경장영양 솔루션에 대한 수요 증가, 튜브를 삽입하는 기술의 발전 등 여러 요인에 의해 이루어지고 있습니다. 주요 촉진요인 중 하나는 고령화이며, 장기 경장영양을 필요로 하는 질환의 발생률이 높아지고 있습니다. 또한, 재택의료 서비스의 확대도 중요한 역할을 하고 있으며, 병원 밖에서 경장영양을 받는 환자가 증가하고 있습니다. 또한, 특히 세계 보건 위기에 대한 대응으로 중환자실과 중환자실 시설의 확대는 응급 및 중환자 치료 장면에서 NG 튜브의 수요를 촉진하고 있습니다. 최소침습적 의료 시술에 대한 관심이 높아지면서 안전성을 높이고, 합병증을 줄이며, 환자 경험을 개선하고, 사용하기 쉬운 NG 튜브가 개발되었습니다. 또한, 의료 연구개발에 대한 지속적인 투자로 기능성을 강화한 차세대 NG 튜브의 도입이 예상되며, 향후 수년간 시장 성장을 더욱 촉진할 것으로 기대됩니다.

부문

환자 유형(성인 환자, 소아 환자, 노인 환자), 적응증 유형(위암, 식도암, IBD, 만성 신장병, 연하곤란, 기타 적응증 유형), 튜브 유형(소구경 피딩 튜브, 대구경 피딩 튜브), 최종사용자(병원·요양시설 최종사용자, 재택 간병 최종사용자)

조사 대상 기업 사례

  • ALCOR Scientific Inc.
  • Amsino International, Inc.
  • Angiplast Pvt. Ltd.
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company(BD)
  • Bicakcilar Medical Devices
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Inc.
  • Fresenius Kabi AG
  • Guangdong Baihe Medical Technology Co. Ltd.
  • Hangzhou Formed Medical Devices Co., Ltd.
  • Medtronic plc
  • Poly Medicure Limited
  • QMD(Qosina Medical Devices)
  • Securmed SpA(Delta Med)
  • Vygon SA

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.01

Global Nasogastric Tubes Market to Reach US$700.1 Million by 2030

The global market for Nasogastric Tubes estimated at US$543.4 Million in the year 2024, is expected to reach US$700.1 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Adult Patients, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$399.9 Million by the end of the analysis period. Growth in the Pediatric Patients segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$148.0 Million While China is Forecast to Grow at 8.0% CAGR

The Nasogastric Tubes market in the U.S. is estimated at US$148.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$144.6 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Nasogastric Tube Market - Key Trends & Drivers Summarized

How Is the Nasogastric Tube Market Evolving to Meet Medical and Nutritional Needs?

The nasogastric (NG) tube market has undergone significant advancements, with improvements in materials, design, and application techniques that enhance patient comfort and treatment efficiency. NG tubes are widely used for enteral feeding, medication administration, and gastric decompression, serving as a critical tool in hospitals, home care settings, and intensive care units (ICUs). Traditional PVC-based tubes have been gradually replaced by softer, biocompatible materials such as silicone and polyurethane, which offer greater flexibility and reduce the risk of mucosal injury. Additionally, the development of anti-clogging and antimicrobial-coated NG tubes has improved patient outcomes by minimizing infections and obstructions. The increasing prevalence of dysphagia, neurological disorders, and gastrointestinal diseases has further driven the demand for nasogastric tubes, particularly in aging populations and critical care patients. The expansion of home healthcare services has also fueled the need for long-term enteral feeding solutions, making NG tubes an essential component in chronic disease management.

Why Is the Demand for Nasogastric Tubes Rising Across Various Healthcare Segments?

The increasing incidence of conditions that require enteral feeding, such as stroke, cancer, and neurological disorders, has led to a significant rise in the use of NG tubes. Hospitals and healthcare facilities rely on these devices for short-term feeding in critically ill patients, while long-term care facilities and home healthcare providers utilize them for sustained nutritional support. The growing prevalence of head and neck cancers, which often lead to swallowing difficulties, has further contributed to market expansion. Additionally, NG tubes play a vital role in emergency and trauma care, where they are used for gastric decompression and aspiration of ingested toxins. The pediatric and neonatal care segments have also witnessed increased demand for NG tubes, as premature infants and infants with congenital abnormalities often require specialized feeding solutions. Furthermore, the rise in surgical procedures requiring post-operative nutritional management has strengthened the market for NG tubes, particularly in gastrointestinal and bariatric surgeries.

How Are Technological Innovations and Regulatory Developments Shaping the Market?

The nasogastric tube industry has seen several innovations aimed at improving safety, reducing complications, and enhancing patient comfort. The introduction of radiopaque and color-coded NG tubes has improved placement verification and reduced misplacement risks, which are critical concerns in NG tube usage. The development of pH-sensitive indicators and electromagnetic placement verification systems has further enhanced tube positioning accuracy, reducing the reliance on X-ray confirmations and minimizing exposure to radiation. Additionally, antimicrobial coatings and hydrogel-based NG tubes are gaining popularity due to their ability to reduce bacterial colonization and prevent infections. Regulatory agencies such as the FDA and European Medicines Agency (EMA) are implementing stricter guidelines to ensure the safety and efficacy of NG tubes, prompting manufacturers to invest in high-quality and standardized products. As healthcare facilities increasingly prioritize infection control and patient safety, the demand for advanced NG tube solutions is expected to grow.

What Are the Key Growth Drivers Boosting the Nasogastric Tube Market?

The growth in the nasogastric tube market is driven by several factors, including the rising prevalence of dysphagia and gastrointestinal disorders, increasing demand for enteral feeding solutions, and advancements in tube placement technologies. One of the primary drivers is the aging population, which has a higher incidence of conditions requiring long-term enteral nutrition. The growing adoption of home healthcare services has also played a crucial role, as more patients receive enteral feeding outside hospital settings. Additionally, the expansion of ICU facilities and critical care units, particularly in response to global health crises, has fueled demand for NG tubes in emergency and intensive care scenarios. The increasing focus on minimally invasive medical procedures has led to the development of user-friendly NG tubes with improved safety features, reducing complications and enhancing patient experience. Moreover, the continued investment in medical research and development is expected to introduce next-generation NG tubes with enhanced functionality, further propelling market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Nasogastric Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients); Indication Type (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Other Indication Types); Tube Type (Small-Bore Feeding Tubes, Large-Bore Feeding Tubes); End-Use (Hospitals & Nursing Homes End-Use, Home Care End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • ALCOR Scientific Inc.
  • Amsino International, Inc.
  • Angiplast Pvt. Ltd.
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Bicakcilar Medical Devices
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Inc.
  • Fresenius Kabi AG
  • Guangdong Baihe Medical Technology Co. Ltd.
  • Hangzhou Formed Medical Devices Co., Ltd.
  • Medtronic plc
  • Poly Medicure Limited
  • QMD (Qosina Medical Devices)
  • Securmed SpA (Delta Med)
  • Vygon SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Nasogastric Tubes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Geriatric and Critically Ill Patient Populations Drive Demand for Long-Term Feeding and Decompression Tubes
    • Increased Incidence of Neurological and Gastrointestinal Disorders Expands Use of Nasogastric Tubes in Hospitals
    • Adoption of Enteral Nutrition in Post-Surgical and Oncology Settings Strengthens Clinical Utility
    • Technological Advancements in Soft-Tip and Radiopaque Tube Designs Improve Safety and Placement Accuracy
    • Growth in ICU and Emergency Care Infrastructure Fuels Demand for Short-Term Gastrointestinal Access Devices
    • Integration of Position Verification Sensors and Imaging Support Tools Enhances Procedural Efficiency
    • Regulatory Guidelines on Enteral Feeding Best Practices Shape Hospital Adoption and Product Standards
    • Expansion of Home Healthcare and Rehabilitation Services Spurs Use of Portable Nasogastric Feeding Kits
    • Use of Antimicrobial Coatings and Biocompatible Polymers Reduces Infection Risks and Enhances Acceptance
    • Rising Awareness of Malnutrition Management in Elderly and Pediatric Populations Supports Early Tube Placement
    • Training Programs for Nurses and Primary Care Providers Increase Comfort with Bedside Insertion Techniques
    • Growth in Demand for Pre-Lubricated and Ready-to-Use Nasogastric Tubes Improves Emergency Response Capabilities
    • Development of Multi-Port and Dual-Lumen Tubes Supports Simultaneous Drainage and Nutrition Delivery
    • Product Differentiation Through Material Flexibility and Kink Resistance Enhances Patient Comfort
    • Focus on Minimizing Tube Misplacement Risks Drives Adoption of Guidewire and Electromagnetic Navigation Systems
    • Availability of Cost-Effective Disposable Tube Options Supports Widespread Use in Resource-Limited Settings
    • Health System Emphasis on Early Nutritional Intervention Propels Nasogastric Tube Utilization in Recovery Plans
    • Manufacturer Collaboration with Dietitians and Gastroenterologists Drives Patient-Centric Product Innovation
    • Global Health Crises and Hospitalization Surges Highlight Critical Role of Nasogastric Tubes in Acute Care
    • Clinical Research on Dwell Time and Tube-Related Complications Informs Design Improvements and Best Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nasogastric Tubes Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nasogastric Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Adult Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Adult Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Adult Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pediatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pediatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pediatric Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Geriatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Geriatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Geriatric Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Small-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Small-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Small-Bore Feeding Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Large-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Large-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Large-Bore Feeding Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Nursing Homes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Nursing Homes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals & Nursing Homes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Home Care End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Stomach Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for IBD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for IBD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for IBD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Chronic Kidney Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Dysphagia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Dysphagia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Dysphagia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Indication Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Indication Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Indication Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • CHINA
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Nasogastric Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Nasogastric Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • INDIA
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Nasogastric Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Nasogastric Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제